BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11096181)

  • 1. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
    Bhatt DL; Kapadia SR; Yadav JS; Topol EJ
    Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy in cerebrovascular disorders.
    Weber R; Brenck J; Diener HC
    Handb Exp Pharmacol; 2012; (210):519-46. PubMed ID: 22918745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
    Harbison JW
    Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S17-20. PubMed ID: 9784798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet agents in stroke prevention. combination therapy: present and future.
    Weksler BB
    Cerebrovasc Dis; 2000; 10 Suppl 5():41-8. PubMed ID: 11096182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy for secondary stroke prevention.
    Forbes CD
    Scott Med J; 1999 Apr; 44(2):54-9. PubMed ID: 10370984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer antiplatelet therapies in stroke prevention.
    Davis SM; Donnan GA
    Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet agents for stroke prevention.
    Paciaroni M; Gallai V
    Cerebrovasc Dis; 2000; 10 Suppl 4():36-9. PubMed ID: 11070399
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral antiplatelet therapy.
    Bernstein RA; Albers GW
    JAMA; 2005 Feb; 293(7):793-4; author reply 794-5. PubMed ID: 15713763
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination antiplatelet agents in ischemic cerebrovascular disease.
    Moussouttas M; Papamitsakis N
    Mt Sinai J Med; 2005 Jan; 72(1):16-22. PubMed ID: 15682258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet treatment in unstable angina: aspirin, clopidogrel, glycoprotein IIb/IIIa antagonist, or all three?
    Harding SA; Boon NA; Flapan AD
    Heart; 2002 Jul; 88(1):11-4. PubMed ID: 12067932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE].
    Alvarez-SabĂ­n J; Montaner-Villalonga J
    Rev Neurol; 1999 Oct 16-31; 29(8):780-4. PubMed ID: 10560115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy in secondary stroke prevention.
    Crawford KM; Talbert RL
    Expert Opin Pharmacother; 2001 Oct; 2(10):1609-13. PubMed ID: 11825303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet drugs.
    Hankey GJ; Eikelboom JW
    Med J Aust; 2003 Jun; 178(11):568-74. PubMed ID: 12765506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet agents in atherothrombotic diseases.
    Rao U; Weston C
    Hosp Med; 2004 Feb; 65(2):72-5. PubMed ID: 14997771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet medications and their indications in preventing and treating coronary thrombosis.
    Van De Graaff E; Steinhubl SR
    Ann Med; 2000 Nov; 32(8):561-71. PubMed ID: 11127934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of platelets in peripheral arterial disease: therapeutic implications.
    Matsagas MI; Geroulakos G; Mikhailidis DP
    Ann Vasc Surg; 2002 Mar; 16(2):246-58. PubMed ID: 11972262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of vascular events in patients with cerebrovascular disease: efficacy and appropriate duration of antiplatelet therapy.
    Habib GB
    Clin Cardiol; 2006 Jun; 29(6):244-8. PubMed ID: 16796073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.